Pathophysiological link between renal and cardiovascular disease in patients with type 2 diabetes mellitus: preliminary results from a proteomic study

被引：0
|
作者：
Mora-Gutierrez, Jose Maria [1 ]
Echeverria Andueza, Saioa [2 ]
Irazusta Olloquiegui, Xabier [3 ]
Ravassa, Susanna [4 ]
Pascual Izco, Marina [3 ]
Escalada San Martin, Francisco Javier [2 ]
Garcia-Fernandez, Nuria [1 ,5 ]
机构：
[1] Clin Univ Navarra, Dept Nephrol, Navarra, Spain
[2] Clin Univ Navarra, Dept Endocrinol, Navarra, Spain
[3] Clin Univ Navarra, Dept Cardiol, Navarra, Spain
[4] Ctr Invest Med Aplicada CIMA, Cardiovasc Res Program, Pamplona, Spain
[5] Inst Salud Carlos III, RICORS Inflammat & Immunopathol Organs & Syst, Madrid, Navarra, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
3011
引用
收藏
页码：I1708 / I1709
页数：2
相关论文
共 50 条
  • [31] Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
    Lorber, Daniel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 169 - 183
  • [32] Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Tsai, Hui-Ju
    Tsai, Wei-Chung
    Hung, Wei-Chun
    Hung, Wei-Wen
    Chang, Chen-Chia
    Dai, Chia-Yen
    Tsai, Yi-Chun
    NUTRIENTS, 2021, 13 (08)
  • [33] Ability of Retinopathy to Predict Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
    Gimeno-Orna, Jose A.
    Faure-Nogueras, Eduardo
    Castro-Alonso, Francisco J.
    Boned-Juliani, Beatriz
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (10): : 1364 - 1367
  • [34] ASSESSMENT OF THERAPEUTIC TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASE
    Grigorescu, E-D
    Lacatusu, C-M
    Onofriescu, A.
    Cazac, G. D.
    Ceasovschih, A.
    Dragoi, S-N
    Grigorescu, A-G
    Sorodoc, L.
    Mihai, B-M
    ATHEROSCLEROSIS, 2022, 355 : E200 - E200
  • [35] Patients with cardiovascular disease and type 2 diabetes mellitus - recommendations for cardiac rehabilitation
    Schwaab, B.
    Karoff, M.
    Voeller, H.
    Wirth, A.
    Witt, T.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (42) : 2152 - 2157
  • [36] Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
    Dominik Lautsch
    Tongtong Wang
    Lingfeng Yang
    Swapnil N. Rajpathak
    Diabetes Therapy, 2019, 10 : 2131 - 2137
  • [37] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S310 - S311
  • [38] Mild renal impairment and cardiovascular outcomes in type 2 diabetes: results from the FIELD study
    Drury, P. L.
    DIABETOLOGIA, 2006, 49 : 6 - 7
  • [39] Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial
    Verma, Subodh
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Mann, Johannes F. E.
    Marso, Steven P.
    Nauck, Michael A.
    Poulter, Neil R.
    Pratley, Richard E.
    Zinman, Bernard
    Michelsen, Marie M.
    Fries, Tea Monk
    Rasmussen, Soren
    Leiter, Lawrence A.
    CIRCULATION, 2018, 137 (20) : 2179 - 2183
  • [40] Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study
    Khawaja, Tasveer
    Linge, Jennifer
    Leinhard, Olof D.
    Al-Kindi, Sadeer G.
    Rajagopalan, Sanjay
    Khera, Amit
    de Lemos, James A.
    Joshi, Parag
    Neeland, Ian J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 78 : 67 - 73
12345